Prime Cabinet Secretary Musalia Mudavadi has commended two Kenyan scientists who are developing a treatment for sickle cell disease.Scedamin is a pediatric formulation of hydroxyurea being developed ...

New research shows that inflammation levels in women with sickle cell disease are higher during the follicular phase of the ...

BabyHUG = Baby Hydroxyurea Group; BP = blood pressure; CPAP/O 2 = continuous positive airways pressure/oxygen; LDH = lactate dehydrogenase; POMS = Prevention of Morbidity in Sickle Cell Disease ...

Sickle Cell Disease is a chronic, inherited blood disorder that affects millions of people worldwide. It is best known for ...

Enrollment is complete for the first groups of sickle cell patients taking pociredir and enrollment has begun for the 20 mg ...

The 5th Global Congress on Sickle Cell Disease is set to take place from June 3 to 6, 2025, at Abuja Continental Hotel in Nigeria, bringing together stakeholders from across the world in the ...

Nagpur: Rashtriya Swayamsevak Sangh's Lok Kalyan Diagnostics launched a sickle cell, thalassaemia awareness campaign, wherein it will provide personalised counselling to patients and conduct blood ...

These states represent about 84% of Medicaid beneficiaries with sickle cell disease. Insurers, however, are wary broadly of the financial costs associated with cell and gene therapies, a report ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access ...

It has been nearly two years since Pfizer’s sickle cell disease (SCD) therapy Oxbryta was approved in the UK, but patients will now be able to access the treatment after an agreement was reached ...